Literature DB >> 28914439

Dampness-Heat Accelerates DMBA-Induced Mammary Tumors in Rats.

Wei Dong1, Xi-Lan Tang2, Guang-Bin Shang3, Guo-Liang Xu3, Wei-Feng Zhu1, Hong-Ning Liu4.   

Abstract

OBJECTIVE: To investigate the impact of dampness-heat (DH) on the development of mammary tumors in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rats.
METHODS: Forty rats were randomly divided into 3 groups in a randomized block design, including the control group (n=13), DMBA group (n=14), and DMBA plus DH group (n=13). Rats in the DMBA group and DMBA plus DH group were intragastrically administrated with DMBA (100 mg/kg) for twice, once per week, while rats in the control group were treated with equivalent volumes of sesame oil. After DMBA administration, rats in the DMBA plus DH group were exposed to a simulated climate chamber with ambient temperature (33.0±0.5°C) and humidity (90%±5%) for 8 weeks, 8 h per day. The body weight, time of tumor formation, and number of tumors were measured weekly to calculate tumor incidence, average latency period, average number of tumors, and average tumor weight. At the end of the experiment, the levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) in serum, and the contents of tumor necrosis factor-α (TNF-α) and interleukin (IL)-1β in serum and tumor tissue were measured, respectively. Some tumor tissues were processed for hematoxylin-eosin staining to determine the histopathological changes.
RESULTS: Compared with DMBA, DMBA plus DH significantly increased the average number of tumors, average tumor weight, levels of serum MMP-9, TIMP-1, TNF-α and IL-1β, and contents of tumor tissue TNF-α and IL-1β (P<0.05 or P<0.01).
CONCLUSION: DH could accelerate the development of mammary tumors through increasing the expressions of MMP-9, TIMP-1, TNF-α and IL-1β in DMBA-induced rats.

Entities:  

Keywords:  7,12-dimethylbenz(a)anthracene; dampness-heat; inflammatory response; mammary tumor

Mesh:

Substances:

Year:  2017        PMID: 28914439     DOI: 10.1007/s11655-017-2821-1

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  27 in total

1.  Chinese medicine approach in clinical practice for breast cancer survivors.

Authors:  Jie-Jia Li; Jian-Ping Fu; Jack Thomas Li
Journal:  Chin J Integr Med       Date:  2011-08-01       Impact factor: 1.978

Review 2.  Inflammation and cancer: breast cancer as a prototype.

Authors:  Alberto Mantovani; Federica Marchesi; Chiara Porta; Antonio Sica; Paola Allavena
Journal:  Breast       Date:  2007-08-30       Impact factor: 4.380

3.  Exploring molecular mechanism underlying Chinese medicine syndrome: a study on correlation between Chinese medicine syndrome and biomarkers for ischemic stroke.

Authors:  Lu Liu; Ying Gao; Bin Ma
Journal:  Chin J Integr Med       Date:  2013-03-25       Impact factor: 1.978

4.  Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.

Authors:  Zheng-Sheng Wu; Qiang Wu; Jiu-Hua Yang; Hong-Qun Wang; Xiang-Dong Ding; Feng Yang; Xiao-Chun Xu
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

5.  Haoqin Qingdan Decoction () and ribavirin therapy downregulate CD14 and toll-like receptor 4 in febrile disease with dampness-heat syndrome in a mouse model.

Authors:  Huan-Huan Luo; Feng-Xue Zhang; Wei Wu; Xin-Hua Wang
Journal:  Chin J Integr Med       Date:  2016-05-05       Impact factor: 1.978

6.  Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer.

Authors:  Karin Söderlund Leifler; Susanne Svensson; Annelie Abrahamsson; Christina Bendrik; Jennifer Robertson; Jack Gauldie; Anna-Karin Olsson; Charlotta Dabrosin
Journal:  J Immunol       Date:  2013-03-15       Impact factor: 5.422

7.  Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.

Authors:  Volkmar Müller; Sabine Riethdorf; Brigitte Rack; Wolfgang Janni; Peter A Fasching; Erich Solomayer; Bahriye Aktas; Sabine Kasimir-Bauer; Julia Zeitz; Klaus Pantel; Tanja Fehm
Journal:  Breast Cancer Res       Date:  2011-07-11       Impact factor: 6.466

8.  Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study.

Authors:  Stine B Thorsen; Sarah Lt Christensen; Sidse O Würtz; Martin Lundberg; Birgitte S Nielsen; Lena Vinther; Mick Knowles; Nick Gee; Simon Fredriksson; Susanne Møller; Nils Brünner; Anne-Sofie Schrohl; Jan Stenvang
Journal:  BMC Cancer       Date:  2013-12-13       Impact factor: 4.430

9.  IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines.

Authors:  XingWu Zhu; Lori A Mulcahy; Rabab A A Mohammed; Andrew H S Lee; Hester A Franks; Laura Kilpatrick; Acelya Yilmazer; E Claire Paish; Ian O Ellis; Poulam M Patel; Andrew M Jackson
Journal:  Breast Cancer Res       Date:  2008-11-17       Impact factor: 6.466

Review 10.  Molecular markers for breast cancer: prediction on tumor behavior.

Authors:  Bruna Karina Banin Hirata; Julie Massayo Maeda Oda; Roberta Losi Guembarovski; Carolina Batista Ariza; Carlos Eduardo Coral de Oliveira; Maria Angelica Ehara Watanabe
Journal:  Dis Markers       Date:  2014-01-28       Impact factor: 3.434

View more
  1 in total

Review 1.  Evidence-Based Dampness-Heat ZHENG (Syndrome) in Cancer: Current Progress toward Establishing Relevant Animal Model with Pancreatic Tumor.

Authors:  Ju-Ying Jiao; Chien-Shan Cheng; Zhang-Qi Cao; Lian-Yu Chen; Zhen Chen
Journal:  Chin J Integr Med       Date:  2022-06-20       Impact factor: 1.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.